[HTML][HTML] Oncologic photodynamic therapy: basic principles, current clinical status and future directions

D Van Straten, V Mashayekhi, HS De Bruijn, S Oliveira… - Cancers, 2017 - mdpi.com
Photodynamic therapy (PDT) is a clinically approved cancer therapy, based on a
photochemical reaction between a light activatable molecule or photosensitizer, light, and …

The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets

SL Wood, M Pernemalm, PA Crosbie… - Cancer treatment …, 2014 - Elsevier
Non-small cell lung cancer (NSCLC) accounts for> 80% of lung cancer cases and currently
has an overall five-year survival rate of only 15%. Patients presenting with advanced stage …

Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer

SJ Antonia, A Villegas, D Daniel… - … England Journal of …, 2017 - Mass Medical Soc
Background Most patients with locally advanced, unresectable, non–small-cell lung cancer
(NSCLC) have disease progression despite definitive chemoradiotherapy (chemotherapy …

Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis

SJ Antonia, H Borghaei, SS Ramalingam… - The Lancet …, 2019 - thelancet.com
Background Phase 3 clinical data has shown higher proportions of patients with objective
response, longer response duration, and longer overall survival with nivolumab versus …

Impact of intensity-modulated radiation therapy technique for locally advanced non–small-cell lung cancer: a secondary analysis of the NRG oncology RTOG 0617 …

SG Chun, C Hu, H Choy, RU Komaki… - Journal of Clinical …, 2017 - ascopubs.org
Purpose Although intensity-modulated radiation therapy (IMRT) is increasingly used to treat
locally advanced non–small-cell lung cancer (NSCLC), IMRT and three-dimensional …

[HTML][HTML] Impact of feature harmonization on radiogenomics analysis: Prediction of EGFR and KRAS mutations from non-small cell lung cancer PET/CT images

I Shiri, M Amini, M Nazari, G Hajianfar, AH Avval… - Computers in biology …, 2022 - Elsevier
Objective To investigate the impact of harmonization on the performance of CT, PET, and
fused PET/CT radiomic features toward the prediction of mutations status, for epidermal …

American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology

LE Schnipper, TJ Smith, D Raghavan… - Journal of Clinical …, 2012 - ascopubs.org
Advancements in the prevention, diagnosis, and treatment of cancer have contributed to
improved survival, better quality of life, and declining death rates in the United States. With …

EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implications

H Yasuda, S Kobayashi, DB Costa - The lancet oncology, 2012 - thelancet.com
Lung cancer is the leading cause of cancer-related death. The identification of epidermal
growth factor receptor (EGFR) somatic mutations defined a new, molecularly classified …

A critical role for the long non‐coding RNA GAS5 in proliferation and apoptosis in non‐small‐cell lung cancer

X Shi, M Sun, H Liu, Y Yao, R Kong… - Molecular …, 2015 - Wiley Online Library
In more recent years, long non‐coding RNAs (lncRNAs) have been investigated as a new
class of regulators of cellular processes, such as cell growth, apoptosis, and carcinogenesis …

[HTML][HTML] An update in clinical utilization of photodynamic therapy for lung cancer

K Wang, B Yu, JL Pathak - Journal of Cancer, 2021 - ncbi.nlm.nih.gov
Lung cancer is one of the leading causes of cancer-related death worldwide, with nearly 1.8
million-diagnosis and 1.59 million deaths. Surgery, radiotherapy, and chemotherapy in …